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Co-expression of cloned sodium channel p,-subunit with the rat skeletal muscle-subunit (Q) accelerated the macroscopic urrent decay, enhanced 
the current amplitude, shifted the steady state inactivation curve to more negative potentials and decreased the time required for complete recovery 
from inactivation. Sodium channels expressed from skeletal muscle mRNA showed a similar behaviour to that observed from cc&,, indicating 
that B, restores ‘physiological’ behaviour. Northern blot analysis revealed that the Na+ channel /$-subunit is present in high abundance (about 
0.1%) in rat heart, brain and skeletal muscle, and the hybridization with untranslated region of the ‘brain’ B, cDNA to skeletal muscle and heart 
mRNA indicated that the diffferent Na’ channel a-subunits in brain, skeletal muscle and heart may share a common /J-subunit. 
Sodium channel; a-Subunit; &Subunit; Xenopus oocyte; Expression; Translational control 
1. INTRODUCTION 
Sodium channels responsible for the fast spread of 
excitation consists of a large ion-conducting &-subunit 
and up to two smaller, associated /?-subunits (/3, and /$) 
[1,2]. The &-subunits cloned from brain and skeletal 
muscle form functional channels when expressed in 
Xenopus oocytes, although with much slower macro- 
scopic inactivation compared with oocytes injected with 
its respective tissue mRNA. Fast (normal) macroscopic 
inactivation was restored by co-injection with low mo- 
lecular weight mRNA from brain or skeletal muscle 
[3-51. The plausible factor in low molecular weight 
mRNA was found to be the /$-subunit [6]. Co-expres- 
sion of a human brain /Ii-subunit with rat skeletal mus- 
cle Na’ channel a-subunit yielded similar observations 
and it was concluded that the functional domains of 
interaction between a-and /%subunits are highly con- 
served [7]. Bennett et al. [8] attributed the effect of 
&subunit to the modulation of gating modes of Na+ 
channel a-subunits. Interestingly, the a-subunit of the 
heart differs as the macroscopic current decay is fast 
upon expression in Xenopus oocytes [9]. 
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We have studied the effect of co-expression of the Na’ 
channel /J-subunit cloned from rat brain on the kinetic 
properties of a,, Na+ channels by measuring whole cell 
currents and compared with those obtained from 
oocytes injected with rat skeletal muscle mRNA. Ex- 
pression of p1 mRNA was evaluated by Northern blot 
analysis using probes from translated and untranslated 
regions of #I, cDNA. 
2. MATERIALS AND METHODS 
2.1. PCR cloning of the B,-subunit 
Rat brain poly(A)+ RNA was reverse transcribed and amplified 
with the polymerase chain reaction using oligonucleotides specific for 
the sodium channel B+ubunit. The primers were designed in a way 
that only two nucleotides of the original GC-rich 5’-UTR were present 
after ligation into a modified version of the pGEM-9zf(-) vector 
containing a polyadenylation sequence at the 3’ end [lo] and a 184 bp 
5’WTR (Sac&NcoI) sequence from the Shaker locus [ll]. The se- 
quence of the coding region was identical to the /I, sequence reported 
by Isom et al. [6]. 
2.2. Northern blot 
mRNA was isolated from adult SpragueDawley rat tissues (brain, 
heart, skeletal muscle and small intestine) and Xenopus oocytes as 
described [12] and poly(A)+ RNA was obtained by purification on an 
oligo(dT)-cellulose column. RNA was separated on a formaldehyde 
agarose gel and transferred to a nylon membrane. The concentration 
and integrity of the RNA samples were confirmed by staining the gel. 
Dilutions of p1 cRNA were used as an internal standard to estimate 
the abundance. For hybridization the B, sodium channel cDNA 
NcoI(218t HindIII(l,474) or the 3’-UTR BanII(89l~HindIII(1,474) 
cDNA fragment was isolated, labelled with digoxigenin dUTP and 
hybridization was performed for 16 h at 5”OC in 50% formamide/ 
0.82 M NaCl. The membrane was washed twice in 0.2 x SSC, 1% SDS 
at 60°C for 15 min. The chemiluminescent detection was done accord- 
ing to the manufacturer’s instructions (Boehringer, Mannheim, Ger- 
many). 
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2.3. Oocyte expression and electrophysiological measurement 
Plasmids were linearized with Not1 and cRNA was transcribed with 
T7 RNA polymerase in the presence of capping nucleotide. After 
removal of unincorporated nucleotides by LiCl precipitation the con- 
centration of the cRNA was measured on a photometer and confirmed 
by electrophoresis. Stage II-V oocytes [13] were injected with 50 nl 
RNA solution (a,,, 5 ng; a,,//?,, 5 rig/l .5 ng (1: 1 molar ratio); skeletal 
muscle mRNA, 25 ng) and were incubated in ND96 (composition in 
mmol/l: NaC196, KC1 2, MgCl* 1, CaCl, 1, HEPES/Na+ 10, pH 7.5) 
supplemented with 100 U/ml penicillin, 100 @ml streptomycin and 
2.5 mM pyruvate, for l-4 days at 21’C. 
Two electrode voltage-clamp recordings were performed with a 
Dagan 8500 amplifier (Dagan, Minneapolis, USA) in ND96 as exter- 
nal bath solution at 22’C. Electrodes were filled with 3 M KC1 and 
had a resistance of 0.3-l Mn. Currents were filtered at 3 kHz (Bessel 
type) and sampled at 15-30 kHz (TL-125 interface) using the PClamp 
5.5 software (Axon Instruments, Burlingame, USA). For analysis 
oocytes with peak currents between 1 ,uA and 3 ,uA were taken. 
3. RESULTS 
Similar effects on the kinetic behaviour to those de- 
scribed by Isom et al. [6] were observed on co-injection 
of aIIa with pi except hat we used a lower concentration 
of pi in a 1:l molar ratio of aIIa to /3, (not shown). 
Subsequently sodium channels were expressed follow- 
ing injection of cRNAs encoding the a,,-subunit, a com- 
bination of ccP1 and /3i cRNAs (a&?,) and rat skeletal 
muscle mRNA into Xenopus Zuevis oocytes. The electro- 
physiological properties are as given below. 
3.1. Sodium current activation and current decay 
The prominent effect of co-expression of /3, was the 
acceleration of macroscopic current decay at all poten- 
tials. Sodium currents expressed from skeletal muscle 
mRNA were similar to those expressed from aP,//3i 
(Fig. 1A and B). The r-values of macroscopic current 
decay plotted against the command potential are illus- 
trated in Fig. 1B. Na’ currents expressed from skeletal 
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muscle mRNA are very close to the Na’ currents pro- 
duced by a&?,. 
Peak currents elicited from a,,/Bi were larger than 
those expressed from the same amount of apI cRNA 
alone (Fig. lC), although there was a considerable var- 
iation among oocytes and also on the time of measure- 
ment following injection. 
3.2. Steady-state inactivation 
Currents from ap,ljll inactivated at more negative po- 
tentials than those expressed from a,, alone (Fig. 2). 
Skeletal muscle mRNA induced currents with an inacti- 
vation behavior similar to the a,,/~,. Currents expressed 
from apI alone showed two components with different 
inactivation behaviour. The fast decaying fraction i ac- 
tivated at quite negative potentials, whereas only the 
slow decaying fraction showed the ‘abnormal’ insensi- 
tivity to depolarizing pulses in absence of the/3,-subunit 
(Fig. 2). The co-expression of pi shifted the inactivation 
curve of aP1 to that derived after injection of skeletal 
muscle mRNA. Again a slight ‘overshoot’ is observed. 
The corresponding values are listed in Table I. 
3.3. Recovery from inactivation 
Sodium currents expressed from aPr and to a lesser 
extent from skeletal muscle mRNA showed a biphasic 
time-course of recovery from inactivation (‘fast’ and 
‘slow’ recovery from inactivation). The fraction of so- 
dium channels exerting slow recovery (f,) was 0.48 for 
sodium currents from a,, alone. This fraction was 
hardly detectable in sodium currents expressed from 
cl,,//& (0.02) and was about 0.1 with mRNA (Fig. 3B). 
Time constants for fast recovery from inactivation were 
comparable in magnitude for aPi (2.0 f 0.4 ms), a&Y, 
(2.3 + 0.5 ms) and skeletal muscle mRNA (3.1 _+ 0.7 
ms) injected oocytes whereas the slow fraction in a@r had 
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Fig. 1. (A) Representative current races of skeletal muscle Na’ channels. Currents were evoked from a holding potential of - 100 mV to the indicated 
potentials in increments of 5 mV. (B) Macroscopic current decay. Time constants of monoexponential current decay (r) were determined by fitting 
a monoexponential function to the sodium current decay at different potentials. (C) Histogram showing the enhancement of the sodium peak current 
measured 4 days after injection of a,,, (5 ng) or a,,& (5 ng and 1.5 ng). 
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a time constant of 1.6 f 0.5 s (see Fig. 3). The original 
traces illustrate that the fraction of aP1 sodium currents 
with slow recovery from inactivation is characterized by 
slow macroscopic current decay whereas the fast frac- 
tion showed fast recovery (Fig. 3A). 
3.4. Northern blot 
Signals were obtained with poly(A+) RNA of brain, 
heart and skeletal muscle. The hybridization with the 3’ 
untranslated region of the brain B1 cDNA showed sig- 
nals of the same size and relative intensities for brain, 
heart and skeletal muscle mRNAs (Fig. 4). No specific 
signal was detectable from rat small intestine and from 
Xenopus oocyte total RNA. By comparision with the 
internal standard the signal obtained from 5 pg of skel- 
etal muscle, heart and brain poly(A)+ RNA corre- 
sponded to 5 ng of cRNA. Assuming an average length 
of tissue mRNAs of 1,500 nucleotides the abundance is 
calculated as 0.1%. 
4. DISCUSSION 
The concentration of /$ that induces functional ef- 
fects with aPIIA is much lower than reported by Isom et 
al. [6] and is most likely due to the removal of the 
GC-rich 5’-UTR, thereby improving the translational 
efficiency in the oocytes [6,7,15,16]. The 5’-UTR region 
from the Shaker potassium channel and an oligo(A),, 
tail present at the end of full-length & transcripts might 
also contribute to this high expression level. Co-expres- 
sion of a,,@, produced an increased peak of the inward 
sodium current when compared to aP1 alone (Fig. 1C). 
A direct comparison with data obtained from single 
channel experiments [17] showed that the open proba- 
bility at the peak current was similar in the presence and 
absence of PI, indicating that co-expression of @I led to 
more functional channels in the membrane. 
Co-expression of /$ shifted the steady-state inactiva- 
tion curve to more negative potentials which is in ac- 
cordance with earlier reports [6,7]. In addition we also 
observed a change in the slope of the inactivation curve. 
This discrepancy in the slope of the inactivation curve 
could be explained by differences in the resolution of the 
voltage clamp. The fast component which inactivates at 
Table I 
Inactivation parameters derived from inactivation curve shown in 
Fig. 2 
%I a,,& poly(A)+ RNA 
&.+ -43.1 f 2.1 - 53.3 + 2.7 - 50.2 ?r 2.2* 
k 10.2 f 0.9 4.8 zk 0.4* 6.0 f 0.9* 
n 8 6 10 
E,., designates the membrane potential (mV) at half maximal steady 
state inactivation, ki the slope at E,,, and n is the number of cells. 
*P C 0.05 vs. a,,. 
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Fig. 2. Steady-state inactivation was measured by holding the oocyte’s 
membrane for at least 5 s at -100 mV followed by an inactivating 100 
ms prepulse to the indicated prep&e potentials and then evoking the 
Na+ current by jumping to -10 mV (mRNA, a,,&?,) or 0 mV (a,,). (A) 
Representative current traces after holding at the indicated prepulse 
potentials. (B) Voltage dependence of steady-state inactivation. Stand- 
ard deviations exceeding the symbol size are shown by vertical bars. 
The smooth curve is a fit to the means with a two-state Boltzmann 
distribution as described 1141: the corresponding values are listed in 
Table I. 
negative potentials of the a current is lost if using cur- 
rent recordings with peak currents which are attained 
~2 ms after the voltage jump (see Fig. 2), and this results 
in no change in the slope of the inactivation curve. 
Changes in activation parameters are not shown due to 
the limitation of the resolution of the two electrode 
voltage clamp. For a reliable measurement of the acti- 
vation parameters, macropatches or the cut open oocyte 
technique [18] has to be employed. 
In contrast to channels expressed from aflI alone that 
show bi-exponential recovery, the a,,/& complex shows 
monoexponential recovery only. As the time constants 
for the fast recovery from inactivation do not differ 
significantly between a,, and a,,/#$ we conclude that in 
both cases sodium channels are in the same gating 
mode. Co- expression of B, practically abolishes the 
slow gating mode under our experimental conditions. 
The kinetics of sodium channels induced by a,,/pl 
closely resembled the gating kinetics of sodium channels 
expressed from mRNA of the native tissue. The slight 
differences between the currents expressed from tissue 
mRNA and that expressed from afil//II may result from 
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an inefficient translation of the tissue message of the 
native fir-subunit in the oocytes. 
Northern blot analysis showed that mRNA encoding 
j?1 is present in high abundance in brain, skeletal muscle 
and heart. Further, it also reveals that the different 
sodium channel a-subunits may share a common j$- 
subunit. This is in accordance with Bennett et al. [8] who 
reported the cloning of a &subunit identical to the 
‘brain’ j&-subunit from heart. These findings are in ap- 
parent contradiction to biochemical studies employing 
antibodies against the &subunit resulting in different 
sizes of &protein from different tissues after SDS- 
PAGE [2]. These differences in the migration behaviour 
of &subunits could be due to a different extent of 
glycosylation of the same protein in different tissues. 
Co-expression of this /?I with the rat heart sodium 
channel a-subunit [ 191 enhanced the peak current with- 
out significant alterations in the electrophysiological 
properties (L. Weigl, unpublished observations) indicat- 
ing that the j&-subunit is also able to interact with the 
heart sodium channel a-subunit. 
28S- 
18S- 
D E 
12345 12345678 
28S- 
18S- 
A 0 I 
-1  
7 1 I I I 1 I 
0123456 
time [ms] 
no/. v mRNA (n-10) 
Fig. 3. Recovery from inactivation was measured by inactivating so- 
dium channels for 100 ms with a supra-threshold pulse to -10 mV, 
then allowing recovery of sodium channels at - 100 mV for a variable 
time interval (At), and then eliciting the peak sodium inward current 
by a pulse to -10 mV. (A) Representative current traces at indicated 
recovery time (At). (B) Rate of recovery vs. time. The vertical bars 
exceeding the symbol size are the standard deviation. The smooth 
curve is derived from a bi-exponential fit through the data points. 
Fig. 4. Northern blot analysis. (A) Ethidium bromide-stained gel. (B) 
Corresponding chemiluminogram hybridized with the full-length p, 
cDNA probe exposed to film for 1 h. Lanes: 1,15 pug brain total RNA; 
2-5, each 5 pg rat poly(A)+ RNA; 2, brain; 3, heart; 4, skeletal muscle; 
5, small intestine; 6, 25 pg Xenopus oocyte total RNA. (C) Internal 
control exposed to tilm for 15 min; lane 1, 10 ng /I, cRNA; lane 2, 
1 ngp, cRNA. (D) Ethidium bromide-stained gel. (E) Corresponding 
chemiluminogram hybridized with a digoxigenin labelled fragment 
from the 3’ untranslated region of the sodium channel (BanII-Hind111 
fragment) (1 h exposure). Lanes: 14, each 5 pg rat poly(A+); 1, brain; 
2, heart; 3, skeletal muscle; 4, intestine; 5,25 pg Xenopus oocyte total 
RNA; 6-8, p, cRNA (100 pg, 1 ng and 10 ng, respectively). 
Although sodium channels induced by a,,/~, closely 
resemble sodium channels induced by skeletal muscle 
mRNA the amount of cRNA required to induce similar 
peak sodium currents is enormous when compared to 
the amount of sodium channel mRNA present in tissue. 
This could be a result of the art&al nature of the in 
vitro cRNA transcripts (inefficient capping, lack of a 
poly(A’) tail) or additional factors present in tissue 
mRNA may be required for a high level expression of 
Na+ currents in Xenopus oocytes. 
Surprising was the high abundance of the /?l mRNA 
in brain, heart and skeletal muscle (about 0.1%) when 
compared to that of the sodium channel a-subunit 
mRNA (O.OOl-O.OOOl%; M. Wallner, unpublished ob- 
servations). This high abundance of B1 in skeletal, mus- 
cle and brain provokes the question of whether the 
translational regulation conferred by the GC-rich 5’- 
UTR region is also active in the native cells. 
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